Figure 3.
A progression model for nonendometrioid (type II) carcinomas. p53 mutations play a critical role in the conversion of atrophic endometrium to an intraepithelial form of serous carcinoma. NE, normal endometrium; EIC, endometrial intraepithelial carcinoma; NEEC, non-endometrioid endometrial carcinoma.